202 related articles for article (PubMed ID: 19334620)
1. [Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases].
Sirotkina OV; Zabotina AM; Berkovich OA; Bazhenova EA; Vavilova TV; Shvartsman AL
Genetika; 2009 Feb; 45(2):247-53. PubMed ID: 19334620
[TBL] [Abstract][Full Text] [Related]
2. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
3. Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene.
Staritz P; Kurz K; Stoll M; Giannitsis E; Katus HA; Ivandic BT
Int J Cardiol; 2009 Apr; 133(3):341-5. PubMed ID: 18485500
[TBL] [Abstract][Full Text] [Related]
4. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
[TBL] [Abstract][Full Text] [Related]
5. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Pampuch A; Cerletti C; de Gaetano G
Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
[TBL] [Abstract][Full Text] [Related]
6. The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
Bouman HJ; van Werkum JW; Rudez G; Leebeek FW; Kruit A; Hackeng CM; Ten Berg JM; de Maat MP; Ruven HJ
Thromb Haemost; 2010 Feb; 103(2):379-86. PubMed ID: 20126830
[TBL] [Abstract][Full Text] [Related]
7. Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions.
Rudez G; Bouman HJ; van Werkum JW; Leebeek FW; Kruit A; Ruven HJ; ten Berg JM; de Maat MP; Hackeng CM
Circ Cardiovasc Genet; 2009 Oct; 2(5):515-21. PubMed ID: 20031628
[TBL] [Abstract][Full Text] [Related]
8. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP.
Hetherington SL; Singh RK; Lodwick D; Thompson JR; Goodall AH; Samani NJ
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):252-7. PubMed ID: 15514209
[TBL] [Abstract][Full Text] [Related]
9. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
10. Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.
Smith SM; Judge HM; Peters G; Armstrong M; Fontana P; Gaussem P; Daly ME; Storey RF
Platelets; 2006 Jun; 17(4):250-8. PubMed ID: 16769602
[TBL] [Abstract][Full Text] [Related]
11. Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients.
Bonello L; Bonello-Palot N; Armero S; Bonello C; Mokhtar OA; Arques S; Dignat-George F; Camoin-Jau L; Paganelli F
Thromb Res; 2010 Apr; 125(4):e167-70. PubMed ID: 19914687
[TBL] [Abstract][Full Text] [Related]
12. PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.
Smith SM; Judge HM; Peters G; Armstrong M; Dupont A; Gaussem P; Storey RF
Platelets; 2005 Sep; 16(6):340-5. PubMed ID: 16194864
[TBL] [Abstract][Full Text] [Related]
13. Effect of P2Y1 and P2Y12 genetic polymorphisms on the ADP-induced platelet aggregation in a Korean population.
Kim KA; Song WG; Lee HM; Joo HJ; Park JY
Thromb Res; 2013 Aug; 132(2):221-6. PubMed ID: 23849096
[TBL] [Abstract][Full Text] [Related]
14. ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay.
Schäfer A; Weinberger S; Flierl U; Eigenthaler M; Störk S; Walter U; Ertl G; Bauersachs J
Thromb Haemost; 2008 Oct; 100(4):618-25. PubMed ID: 18841284
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
[TBL] [Abstract][Full Text] [Related]
16. P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.
Fontana P; Gaussem P; Aiach M; Fiessinger JN; Emmerich J; Reny JL
Circulation; 2003 Dec; 108(24):2971-3. PubMed ID: 14662702
[TBL] [Abstract][Full Text] [Related]
17. P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting.
Zoheir N; Abd Elhamid S; Abulata N; El Sobky M; Khafagy D; Mostafa A
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):525-31. PubMed ID: 23751603
[TBL] [Abstract][Full Text] [Related]
18. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
Cavallari U; Trabetti E; Malerba G; Biscuola M; Girelli D; Olivieri O; Martinelli N; Angiolillo DJ; Corrocher R; Pignatti PF
BMC Med Genet; 2007 Sep; 8():59. PubMed ID: 17803810
[TBL] [Abstract][Full Text] [Related]
19. Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
Lordkipanidzé M; Pharand C; Nguyen TA; Schampaert E; Diodati JG
Ther Drug Monit; 2008 Jun; 30(3):372-8. PubMed ID: 18520610
[TBL] [Abstract][Full Text] [Related]
20. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
